AtriCure, Inc.
ATRC
$29.82
$0.290.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 140.50M | 134.27M | 136.14M | 123.62M | 124.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 140.50M | 134.27M | 136.14M | 123.62M | 124.28M |
| Cost of Revenue | 35.16M | 32.94M | 34.66M | 30.99M | 31.66M |
| Gross Profit | 105.34M | 101.33M | 101.48M | 92.63M | 92.62M |
| SG&A Expenses | 78.34M | 78.23M | 78.39M | 76.05M | 72.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 138.01M | 134.06M | 142.33M | 129.57M | 138.80M |
| Operating Income | 2.49M | 208.00K | -6.19M | -5.95M | -14.52M |
| Income Before Tax | 2.36M | -86.00K | -5.93M | -6.51M | -15.30M |
| Income Tax Expenses | 604.00K | 181.00K | 261.00K | 239.00K | 266.00K |
| Earnings from Continuing Operations | 1.76M | -267.00K | -6.19M | -6.75M | -15.57M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.76M | -267.00K | -6.19M | -6.75M | -15.57M |
| EBIT | 2.49M | 208.00K | -6.19M | -5.95M | -14.52M |
| EBITDA | 7.60M | 5.38M | -1.02M | -870.00K | -9.70M |
| EPS Basic | 0.04 | -0.01 | -0.13 | -0.14 | -0.33 |
| Normalized Basic EPS | 0.03 | 0.00 | -0.08 | -0.09 | -0.20 |
| EPS Diluted | 0.04 | -0.01 | -0.13 | -0.14 | -0.33 |
| Normalized Diluted EPS | 0.03 | 0.00 | -0.08 | -0.09 | -0.20 |
| Average Basic Shares Outstanding | 47.96M | 47.92M | 47.72M | 47.39M | 47.13M |
| Average Diluted Shares Outstanding | 48.87M | 47.92M | 47.72M | 47.39M | 47.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |